Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Viral”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02604017
What this trial is testing

Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Subjects With Genotype 1 Infection

Who this might be right for
Chronic Hepatitis CHepatitis C VirusHCV
AbbVie 703
Testing effectiveness (Phase 2)Study completedNCT04075916
What this trial is testing

A Trial of Transplanting Hepatitis C Kidneys Into Hepatitis C-Negative Kidney Recipients

Who this might be right for
End Stage Renal Disease
University of Pennsylvania 201
Not applicableEnded earlyNCT02503735
What this trial is testing

Effect of Harvoni on Proteinuria and eGFR in Hepatitis C Virus Associated Chronic Kidney Disease (CKD)

Who this might be right for
Hepatitis CChronic Kidney Disease
Massachusetts General Hospital 14
Testing effectiveness (Phase 2)Study completedNCT00382798
What this trial is testing

Adaptive Phase I HCV Study With Nucleoside Analogue, in Combination With Interferon and Ribavirin

Who this might be right for
Healthy VolunteersHepatitis C Virus
Pharmasset 75
Not applicableLooking for participantsNCT05390424
What this trial is testing

Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot

Who this might be right for
Hepatitis BHepatitis CAIDS
University Hospital, Rouen 500
Not applicableStudy completedNCT02439918
What this trial is testing

Epidemic History and Iatrogenic Transmission of Blood-borne Viruses in Mid-20th Century Kinshasa

Who this might be right for
HIVHTLV-1Hepatitis C, Chronic
Université de Sherbrooke 839
Not applicableStudy completedNCT02581020
What this trial is testing

The Durability of Response and Persistence of Resistance to AbbVie's 2 Direct-acting Antiviral Agent (2D) Therapy in Japanese Subjects

Who this might be right for
Hepatitis C Virus
AbbVie 344
Not applicableStudy completedNCT01143896
What this trial is testing

Hepatitis C Translating Initiatives for Depression Into Effective Solutions

Who this might be right for
Hepatitis CDepression
VA Office of Research and Development 309
Early research (Phase 1)Study completedNCT01217359
What this trial is testing

Differences in Evoked Intracellular Interferon Signaling Pathways Using Single Cell Phosphoprotein Profiling

Who this might be right for
Hepatitis C
University of North Carolina, Chapel Hill 22
Post-approval studies (Phase 4)Study completedNCT00353418
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 415
Post-approval studies (Phase 4)WithdrawnNCT03381859
What this trial is testing

Clinical Trial to eLiminate HCV-infection in Treatment-naïve, Renally Impaired EgyptiAn Patients on Renal Dialysis, With Chronic Hepatitis C Genotype 4

Who this might be right for
Hepatitis C Virus Infection, Response to Therapy of
University of Maryland, Baltimore
Post-approval studies (Phase 4)Study completedNCT00474955
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis C and Chronic Renal Failure.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 27
Early research (Phase 1)Study completedNCT01134718
What this trial is testing

TMC435-TiDP16-C119 - A Study Comparing 2 New Capsule Formulations of TMC435 to an Established Capsule Formulation and Evaluating the Respective Blood Levels of TMC435 Following Single Dose Administration

Who this might be right for
Hepatitis C Virus
Tibotec Pharmaceuticals, Ireland 24
Early research (Phase 1)Study completedNCT00938899
What this trial is testing

TMC435350-TiDP16-C101 - A Study to Examine the Safety, Tolerability and Pharmacokinetics of Increasing Oral Doses of TMC435350 After Single and Repeated Dosing

Who this might be right for
Hepatitis C
Tibotec Pharmaceuticals, Ireland 55
Post-approval studies (Phase 4)Study completedNCT00844272
What this trial is testing

Psychoeducation Reaches HCV-infected Methadone/Buprenorphine Substituted Patients in Standard Antiviral Treatment

Who this might be right for
Intravenous Drug AbuseChronic Hepatitis C
Universitätsklinikum Hamburg-Eppendorf 189
Testing effectiveness (Phase 2)Study completedNCT00418639
What this trial is testing

Study of Nitazoxanide in the Treatment of Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Romark Laboratories L.C. 50
Early research (Phase 1)Study completedNCT01038167
What this trial is testing

Examine the Effects of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus in Healthy Adults

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 20
Not applicableEnrolling By InvitationNCT05248919
What this trial is testing

Therapy for Hepatitis C Virus (HCV) in Primary Treatment Failure in Pakistan

Who this might be right for
Hepatitis C
Queen Mary University of London 318
Large-scale testing (Phase 3)Study completedNCT03186365
What this trial is testing

8 Weeks Versus 12 Weeks of Elbasvir/Grazoprevir in Treatment-naïve CHC With Mild Fibrosis

Who this might be right for
Hepatitis C, Chronic
Kaohsiung Medical University Chung-Ho Memorial Hospital 82
Testing effectiveness (Phase 2)Study completedNCT02301936
What this trial is testing

Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 or 24 Weeks in Genotype 1 or 4 HCV Infected Adults With Sickle Cell Disease

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 10
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation